Gregory D. Davis

Insider Reports History

Location
C/O Sangamo Therapeutics, Inc., 501 Canal Blvd., Richmond, CA
Signature
/s/ Scott Willoughby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory D. Davis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC Head of Research & Technology Common Stock 194K $80.7K $0.42 Nov 24, 2025 Direct
SANGAMO THERAPEUTICS, INC Head of Research & Technology Stock Option (Right to Buy) 99.5K Feb 25, 2025 Direct

Insider Reports Filed by Gregory D. Davis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMO SANGAMO THERAPEUTICS, INC Nov 24, 2025 1 -$301 4 Nov 26, 2025 Head of Research & Technology
SGMO SANGAMO THERAPEUTICS, INC Oct 22, 2025 1 -$4.43K 4 Oct 24, 2025 Head of Research & Technology
SGMO SANGAMO THERAPEUTICS, INC Aug 24, 2025 1 -$424 4 Aug 26, 2025 Head of Research & Technology
SGMO SANGAMO THERAPEUTICS, INC Jul 22, 2025 1 -$3.22K 4 Jul 24, 2025 Head of Research & Technology
SGMO SANGAMO THERAPEUTICS, INC May 24, 2025 1 -$342 4 May 28, 2025 Head of Research & Technology
SGMO SANGAMO THERAPEUTICS, INC Apr 22, 2025 1 -$5.21K 4 Apr 24, 2025 Head of Research & Technology
SGMO SANGAMO THERAPEUTICS, INC Feb 24, 2025 4 -$1.19K 4 Feb 26, 2025 Head of Research & Technology
SGMO SANGAMO THERAPEUTICS, INC Jan 22, 2025 1 -$35K 4 Jan 24, 2025 Head of Research & Technology
SGMO SANGAMO THERAPEUTICS, INC Nov 24, 2024 2 -$2.34K 4 Nov 26, 2024 Head of Research & Technology
SGMO SANGAMO THERAPEUTICS, INC Oct 18, 2024 0 $0 3 Oct 28, 2024 Head of Research & Technology